What is the evaluation and management of a left partially duplicated system with a non-functioning lower moiety due to primary Ureteropelvic Junction Obstruction (UPJO)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evaluation and Management of Left Partially Duplicated System with Non-Functioning Lower Moiety Secondary to Primary UPJO

For a non-functioning lower moiety (<10% differential function) in a partially duplicated system with UPJO, proceed directly to lower pole hemi-nephrectomy rather than attempting reconstructive surgery, as preservation efforts are futile when function is already lost. 1, 2

Initial Diagnostic Evaluation

Imaging Protocol

  • Obtain renal ultrasound to confirm hydronephrosis of the lower moiety, assess parenchymal thickness, and identify the "Y-shaped" ureteral confluence characteristic of incomplete duplication 3, 1

  • Perform Tc-99m MAG3 diuretic renal scan (preferred over DTPA) to quantify differential function of the lower moiety and document drainage patterns with T1/2 washout curves 4

    • MAG3 is superior due to 40-50% extraction fraction versus DTPA's 20%, providing better visualization in obstructed systems 4
    • Delay until at least 2 months of age due to immature glomerular filtration in neonates 4
  • Consider CT urography or MR urography to define complex anatomy, particularly the distance from the UPJO to the ureteral confluence, which determines surgical approach 4, 3, 1

    • MRU provides detailed morphologic information without radiation but may require sedation in young children 4, 3

Functional Assessment Criteria

  • Document differential renal function of the lower moiety specifically 4
    • <40% differential function indicates severely compromised moiety 4
    • <10% function is generally considered non-salvageable 1, 2
  • Assess drainage with T1/2 >20 minutes indicating obstruction 4

Management Algorithm Based on Lower Moiety Function

Non-Functioning Lower Moiety (<10% Function)

Proceed to lower pole hemi-nephrectomy as the definitive treatment 1, 2, 5

  • Reconstructive attempts are not justified when parenchyma is already non-functional 5
  • This prevents future complications including recurrent infections, pain, and stone formation 6
  • Preserves the functioning upper moiety without risk of iatrogenic injury from complex reconstruction 1, 2

Functioning Lower Moiety (>40% Function)

Surgical approach depends on anatomic distance from UPJO to ureteral confluence: 1, 2

Short Distance (≤3 cm from UPJO to confluence)

  • Perform end-to-side pyeloureterostomy of the lower pelvis to the ureteral confluence 1, 2
  • This utilizes the non-obstructed upper pole ureter as drainage conduit 2
  • Can be performed open or laparoscopically 1

Long Distance (>3 cm from UPJO to confluence)

  • Perform dismembered pyeloplasty of the lower moiety 1, 2
  • Standard Anderson-Hynes technique adapted for duplex anatomy 1
  • Laparoscopic or robotic approach is feasible with appropriate expertise 1, 6

Borderline Function (10-40% Function)

Individualized decision based on: 4

  • Deteriorating function (>5% decline on consecutive scans) mandates intervention to prevent complete loss 4
  • Stable marginal function with symptoms (pain, recurrent UTI) favors hemi-nephrectomy over complex reconstruction 1, 5
  • Improving function in young infants may warrant observation with serial MAG3 scans every 3-6 months 7, 8

Perioperative Considerations

Antibiotic Prophylaxis

  • Do NOT routinely prescribe continuous antibiotic prophylaxis for isolated UPJO in duplex systems, as data shows no benefit 7, 8
  • Consider prophylaxis only if additional high-risk features present: female gender, distal ureteral dilation ≥7 mm, or concurrent vesicoureteral reflux 7, 8

Voiding Cystourethrography (VCUG)

  • Obtain VCUG if moderate-to-severe hydronephrosis present to exclude vesicoureteral reflux, which occurs in 30% of duplex anomalies 4, 3
  • Essential in males to rule out posterior urethral valves causing bilateral pathology 4, 8

Crossing Vessels Assessment

  • Identify crossing vessels at the UPJO during preoperative imaging, present in approximately 50% of lower pole UPJO cases 1, 2
  • Crossing vessels necessitate dismembered pyeloplasty with vessel transposition rather than pyeloureterostomy 1, 2

Critical Pitfalls to Avoid

  • Do not attempt complex reconstruction on a non-functioning moiety (<10% function), as this exposes the patient to operative risk without functional benefit 1, 5
  • Do not assume all hydronephrosis indicates obstruction—ensure MAG3 scan confirms poor drainage (T1/2 >20 min) before proceeding to surgery 4, 8
  • Do not overlook the upper moiety—ensure it is not obstructed or refluxing, as bilateral pathology changes management 3, 5
  • Avoid endoscopic approaches (endopyelotomy) in duplex systems with complex anatomy, as success rates are significantly lower (50% vs 73% in single systems) and risk injury to the upper moiety ureter 3, 9
  • Ensure adequate hydration before MAG3 scan, as dehydration masks obstruction and yields false-negative results 3

Postoperative Surveillance

  • Obtain ultrasound at 1-3 months post-surgery to document resolution of hydronephrosis 7, 3
  • Repeat MAG3 scan at 3-6 months to confirm improved drainage (T1/2 <20 min) and stable/improved differential function 4
  • Annual ultrasound surveillance for at least 2 years to detect late complications or contralateral pathology 3

References

Guideline

Management of Duplex Collecting System in the Kidney

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Congenital Pelvic Ureteric Junction (PUJ) Obstruction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Ureteral Obstructions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the recommended treatment for a 19-year-old patient with a 5.5mm Ureteropelvic Junction (UPJ) stone and moderate hydronephrosis?
Are renal stones more uncomfortable when located at the ureteropelvic junction (UPJ) or in the lower pole of the kidney?
What is the treatment for mild left hydroureteronephrosis secondary to a 2mm calculus at the left ureterovesical junction?
What are the 5 most frequent causes of hydronephrosis in newborns, infants, preschoolers, school-aged children, and adolescents?
What is the best management for a 78-year-old man with stage IV (four) adenocarcinoma of the prostate, presenting with left hydronephrosis (kidney swelling due to obstruction) and impaired renal function (elevated serum creatinine), after previous treatment with bilateral orchiectomy (surgical removal of testes)?
What is the 5-year survival rate for a patient with Acute Myeloid Leukemia (AML) who underwent chemotherapy initially and then required a bone marrow transplant due to recurrence?
What are the alternative antiplatelet therapies for a patient with a confirmed ticagrelor (Brilinta) allergy?
Is Disudrin (generic name not specified) effective for treating rheumatic heart disease?
What is the recommended cycling protocol for steroid injections, specifically corticosteroids (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)), in an adult male?
Is blood pressure reading indicative of spinal anesthesia level?
What labs and initial management are recommended for pediatric patients suspected of sepsis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.